CC(C)(C)S(=O)(=O)N1C[C@H]2C(=CC[C@@H]3C(=O)N(c4ccccc4)C(=O)[C@@H]32)[C@H]1CCO
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?